4//SEC Filing
Jenkins Annalisa 4
Accession 0000950170-25-015417
CIK 0001719714other
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 4:30 PM ET
Size
8.0 KB
Accession
0000950170-25-015417
Insider Transaction Report
Form 4
Jenkins Annalisa
Director
Transactions
- Award
Deferred Restricted Stock Units
2025-02-05+15,243→ 15,243 total→ American Depository Shares (15,243 underlying) - Award
Share Options (Right to buy)
2025-02-05+55,000→ 55,000 totalExercise: $3.16Exp: 2035-02-05→ American Depositary Shares (55,000 underlying)
Footnotes (3)
- [F1]Vests in substantially equal monthly installments over a one year period from the February 5, 2025 grant date
- [F2]Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer
- [F3]Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.
Documents
Issuer
Mereo BioPharma Group plc
CIK 0001719714
Entity typeother
Related Parties
1- filerCIK 0001639481
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 4:30 PM ET
- Size
- 8.0 KB